CLINICAL_TRIALS ClinicalTrials.gov record update

Early, Risk Adapted CC-99282 + Rituximab Post CAR T-Cell Therapy for Non-Hodgkin's Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06209619
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:21.028226+00:00
Published At: 2026-02-27T00:00:00+00:00
Record Updated At: 2026-02-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["B-Cell Non-Hodgkin Lymphoma-Recurrent", "Diffuse Large B-Cell Lymphoma-Recurrent", "Follicular Lymphoma-Recurrent", "High Grade B-Cell Lymphoma-Recurrent", "Primary Mediastinal Large B-Cell Lymphoma-Recurrent", "Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent", "B-Cell Non-Hodgkin Lymphoma-Refractory", "Diffuse Large B-Cell Lymphoma-Refractory", "Follicular Lymphoma-Refractory", "High Grade B-Cell Lymphoma-Refractory", "Primary Mediastinal Large B-Cell Lymphoma-Refractory", "Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Refractory"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-02-27"
protocolSection.identificationModule.nctId: "NCT06209619"
protocolSection.identificationModule.officialTitle: "Early, Risk Adapted CC-99282 + Rituximab Post CAR T-Cell Therapy for Non-Hodgkin\u0027s Lymphoma"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.